Page 55 - SaxoCell Annual Report22/23
P. 55
With regard to the concrete preparation of clinical work, the SaxoCellCLINICS platform has already
taken various measures. It is cooperating closely with the SaxoCell project "ECP-CAR", which is
working on the development of a clinical trial with CAR-T cells and is also providing patient
samples for translational analyses in the context of CAR-T cell therapies in order to understand the
effect of ECP treatment in the context of such a therapy. The platform is also supporting the
design of a CAR-NK cell therapy trial in myelodysplastic neoplasia (MDS)/acute myeloid leukemia
(AML). For the ECP-CAR project, the platform is working on the application for manufacturing
authorization for the ECP procedure and corresponds regularly with the PEI.
Overall, the SaxoCell Clinics
platform has made significant
progress in supporting and
coordinating clinical trials in
the Saxo Cell Cluster. It helps
to improve the translation of
research results into clinical
application and to provide a
solid basis for future cli-nical
projects.
The fields of activity of SaxoCellCLINICS
50
